These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27814820)

  • 121. The Effect of the Controversial US Preventive Services Task Force Recommendations on the Use of Screening Mammography.
    Sharpe RE; Levin DC; Parker L; Rao VM
    J Am Coll Radiol; 2016 Nov; 13(11S):e58-e61. PubMed ID: 27814825
    [TBL] [Abstract][Full Text] [Related]  

  • 122. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
    Butler JR; Furnival CM; Hart RF
    Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
    [TBL] [Abstract][Full Text] [Related]  

  • 123. False-positive screening mammograms and biopsies among women participating in a Canadian provincial breast screening program.
    Coldman AJ; Phillips N
    Can J Public Health; 2012 Nov; 103(6):e420-4. PubMed ID: 23618020
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Mammographic screening of women aged 40-49 years. Benefit, risk, and cost considerations.
    Feig SA
    Cancer; 1995 Nov; 76(10 Suppl):2097-106. PubMed ID: 8635007
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women.
    Goldman LE; Walker R; Miglioretti DL; Smith-Bindman R; Kerlikowske AK;
    Med Care; 2012 Mar; 50(3):210-6. PubMed ID: 22186768
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Current status of screening mammography.
    Feig SA
    Obstet Gynecol Clin North Am; 2002 Mar; 29(1):123-36. PubMed ID: 11892862
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Screening mammography: a surgeon's strategy for dealing with abnormal mammographic findings.
    Muskett A; McGreevy JM
    Am J Surg; 1987 Dec; 154(6):589-92. PubMed ID: 3425799
    [TBL] [Abstract][Full Text] [Related]  

  • 128. An Abbreviated Protocol for High-Risk Screening Breast MRI Saves Time and Resources.
    Harvey SC; Di Carlo PA; Lee B; Obadina E; Sippo D; Mullen L
    J Am Coll Radiol; 2016 Nov; 13(11S):R74-R80. PubMed ID: 27814819
    [TBL] [Abstract][Full Text] [Related]  

  • 129. The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs.
    van der Poort EKJ; van Ravesteyn NT; van den Broek JJ; de Koning HJ
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740615
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Development of a clinical decision rule for triage of women with palpable breast masses.
    Reeves MJ; Osuch JR; Pathak DR
    J Clin Epidemiol; 2003 Jul; 56(7):636-45. PubMed ID: 12921932
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Immediate biopsy versus observation for abnormal findings on mammograms: an analysis of potential outcomes and costs.
    Velanovich V
    Am J Surg; 1995 Oct; 170(4):327-32. PubMed ID: 7573723
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Mammography and breast cancer screening.
    Bassett LW; Manjikian V; Gold RH
    Surg Clin North Am; 1990 Aug; 70(4):775-800. PubMed ID: 2196705
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Results of the first year of breast cancer screening in a district hospital.
    Bird DL; Fox JN; Ashley S; Imrie MJ
    Br J Surg; 1992 Sep; 79(9):922-4. PubMed ID: 1422757
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Perceived sensitivity of mammographic screening: women's views on test accuracy and financial compensation for missed cancers.
    Barratt A; Cockburn J; Furnival C; McBride A; Mallon L
    J Epidemiol Community Health; 1999 Nov; 53(11):716-20. PubMed ID: 10656101
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Combined texture analysis and machine learning in suspicious calcifications detected by mammography: Potential to avoid unnecessary stereotactical biopsies.
    Stelzer PD; Steding O; Raudner MW; Euller G; Clauser P; Baltzer PAT
    Eur J Radiol; 2020 Nov; 132():109309. PubMed ID: 33010682
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs.
    Tosteson ANA; Yang Q; Nelson HD; Longton G; Soneji SS; Pepe M; Geller B; Carney PA; Onega T; Allison KH; Elmore JG; Weaver DL
    Breast Cancer Res Treat; 2018 Jan; 167(1):195-203. PubMed ID: 28879558
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review.
    Barratt AL; Les Irwig M; Glasziou PP; Salkeld GP; Houssami N
    Med J Aust; 2002 Mar; 176(6):266-71. PubMed ID: 11999259
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Simulated lifetime costs of three types of employer-based, periodic, breast cancer screening programs for working-age women.
    Griffiths RI; Griffiths CB; Powe NR
    Am J Health Promot; 1994; 9(2):137-46. PubMed ID: 10150714
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Diagnostic invasiveness and psychosocial consequences of false-positive mammography.
    Heleno B; Siersma VD; Brodersen J
    Ann Fam Med; 2015; 13(3):242-9. PubMed ID: 25964402
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Breast cancer screening in a private women's clinic.
    Tifft JG; Jarjoura D
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 1):1402-7. PubMed ID: 3381864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.